Baird lowered the firm’s price target on Iqvia to $245 from $254 and keeps a Neutral rating on the shares. The firm said they squeaked out minor 1Q24 upside versus Street, though absolute growth of revenue, EBITDA , and EPS, remained sluggish, while the company talked down 2Q expectations.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IQV: